Literature DB >> 7941679

[Cardiopulmonary exercise capacity before and after heart transplantation].

M Sigmund1, F J Beck, J Silny, C Reupcke, U Desch, P Hanrath.   

Abstract

The aim of heart transplantation is to improve survival and exercise capacity of patients with endstage heart failure. Fifteen patients (1 female, 14 male) with a mean age of 48 years (ranging from 25-62) underwent cardiopulmonary exercise testing (CPX) before heart transplantation. 10/15 patients showed an oxygen uptake of < 4 ml/min/kg (Weber E) at the anaerobic threshold and 5/15 an oxygen uptake between 5 and 8 ml/min/kg (Weber D), so that a severe respectively very severe limitation of exercise capacity was documented before transplantation. Up to now 9/15 patients underwent heart transplantation. Cardiopulmonary exercise test could be repeated in 7 of these 9 patients, 12 up to 22 weeks following operation. Exercise capacity improved from former Weber-class E to class B in 2/5 patients, to class C in 2/5 patients, and to class D in 1/5 patient. Both patients with a preoperative class D improved to class C. Thus, in all cardiac recipients exercise capacity increased, whereas normal values were not reached. The denervation of cardiac allografts leads to a higher heart rate at rest, a delayed increase and diminished slope of exercise response and reduced heart rates at maximal effort. In 17 heart transplant recipients (3 female, 14 male) with a mean age of 53 years (ranging from 25-62), we investigated the exercise capacity with respect to the abnormal rate regulation of the donor heart, which was quantified by comparing the corresponding rate regulation of the remaining part of recipient's atrium driven by the sinus mode.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7941679

Source DB:  PubMed          Journal:  Z Kardiol        ISSN: 0300-5860


  1 in total

1.  Ischemic time as a predictor of physical recovery in the first months after heart transplantation.

Authors:  Francisco Buendía-Fuentes; Luis Almenar-Bonet; Luis Martínez-Dolz; Ignacio Sánchez-Lázaro; María Rodríguez-Serrano; Diana Domingo-Valero; María José Sancho-Tello de Carranza; Antonio Salvador-Sanz
Journal:  ISRN Cardiol       Date:  2012-06-18
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.